CEO, Board Member, Advisor
AM
Adagio Medical Inc.
Adagio Medical is developing catheter-based therapies that utilize advanced ablation techniques to treat atrial fibrillation and other cardiovascular conditions. The company aims to improve patient outcomes by providing targeted interventions that reduce the risk of stroke and enhance heart rhythm stability.
- Biotechnology
- Healthcare Technology
- Medical Devices
Updated 7 months ago
Funding
Raised to date
$9.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Atrial fibrillation and other cardiovascular conditions often require invasive procedures like catheter ablation, which can carry risks and may not always provide long-term solutions. Current ablation techniques may lack precision, potentially leading to incomplete lesion formation or damage to surrounding tissues. This can result in recurrence of arrhythmias and the need for repeat procedures.
Solution
Adagio Medical is developing catheter-based therapies that utilize pulsed field ablation (PFA) to treat atrial fibrillation and other cardiovascular conditions. Their technology aims to improve patient outcomes by delivering targeted energy to cardiac tissue, creating durable lesions while minimizing the risk of collateral damage. The PFA approach offers a non-thermal ablation method that selectively targets cardiomyocytes, potentially reducing the incidence of complications associated with traditional radiofrequency ablation. By providing a more precise and controlled ablation, Adagio Medical seeks to enhance heart rhythm stability and reduce the likelihood of arrhythmia recurrence.
Target Audience
The primary target audience includes electrophysiologists and interventional cardiologists who treat patients with atrial fibrillation and other cardiovascular arrhythmias.
Features
- Catheter-based system for targeted pulsed field ablation (PFA)
- Non-thermal ablation technology to minimize damage to surrounding tissues
- Precise energy delivery for effective lesion formation
- Designed to improve heart rhythm stability
- Aims to reduce the risk of arrhythmia recurrence